Ozempic shortage pain to continue until year’s end

TGA underscores ‘limited availability’ means drug should still only be prescribed for type-2 diabetes There will be continued “limited availability” of diabetes drug Ozempic until 31 December 2023 due to “unexpected increase in consumer demand” the Therapeutic Goods Administration (TGA) has announced on its website. The TGA update comes just as the theoretical June 30